Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6293295rdf:typepubmed:Citationlld:pubmed
pubmed-article:6293295lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0006684lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0086907lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0028066lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0005823lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0232117lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0085580lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:6293295lifeskim:mentionsumls-concept:C0949236lld:lifeskim
pubmed-article:6293295pubmed:issue6lld:pubmed
pubmed-article:6293295pubmed:dateCreated1983-1-7lld:pubmed
pubmed-article:6293295pubmed:abstractTextTen milligrams nifedipine was administered orally to young and old persons with or without hypertension, and the acute effects of nifedipine on the renin-angiotensin-aldosterone system were studied one half to 3 hours later. Nifedipine reduced blood pressure and increased pulse rate in young and old persons with or without hypertension. Simultaneously, nifedipine produced a significant increase of plasma renin activity in young persons with or without hypertension but failed to do so in old persons with or without hypertension. As a result, angiotensin I and II increased significantly in young persons but not in old persons. Hydralazine elevated aldosterone concentration by stimulating the renin-angiotensin system but nifedipine failed to do so despite its effect on the renin-angiotensin system in young individuals. Since calcium is required to secrete aldosterone, it is suggested that nifedipine blocked aldosterone secretion by the agent's calcium antagonizing action.lld:pubmed
pubmed-article:6293295pubmed:languageenglld:pubmed
pubmed-article:6293295pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6293295pubmed:statusMEDLINElld:pubmed
pubmed-article:6293295pubmed:monthDeclld:pubmed
pubmed-article:6293295pubmed:issn0002-8703lld:pubmed
pubmed-article:6293295pubmed:authorpubmed-author:YamadaTTlld:pubmed
pubmed-article:6293295pubmed:authorpubmed-author:KubotaTTlld:pubmed
pubmed-article:6293295pubmed:authorpubmed-author:HiramatsuKKlld:pubmed
pubmed-article:6293295pubmed:authorpubmed-author:YamagishiFFlld:pubmed
pubmed-article:6293295pubmed:issnTypePrintlld:pubmed
pubmed-article:6293295pubmed:volume104lld:pubmed
pubmed-article:6293295pubmed:ownerNLMlld:pubmed
pubmed-article:6293295pubmed:authorsCompleteYlld:pubmed
pubmed-article:6293295pubmed:pagination1346-50lld:pubmed
pubmed-article:6293295pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:meshHeadingpubmed-meshheading:6293295-...lld:pubmed
pubmed-article:6293295pubmed:year1982lld:pubmed
pubmed-article:6293295pubmed:articleTitleAcute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension.lld:pubmed
pubmed-article:6293295pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6293295pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6293295lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6293295lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6293295lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6293295lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6293295lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6293295lld:pubmed